Related references
Note: Only part of the references are listed.Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary
Ashour Ahmed Ahmed et al.
JOURNAL OF PATHOLOGY (2010)
TRAIL treatment provokes mutations in surviving cells
M. M. Lovric et al.
ONCOGENE (2010)
The transcription-independent mitochondrial p53 program is a major contributor to nutlin-induced apoptosis in tumor cells
Angelina V. Vaseva et al.
CELL CYCLE (2009)
Transient Nutlin-3a Treatment Promotes Endoreduplication and the Generation of Therapy-Resistant Tetraploid Cells
Hong Shen et al.
CANCER RESEARCH (2008)
Nutlin-3a activates p53 to both down-regulate inhibitor of growth 2 and up-regulate mir-34a, mir-34b, and mir-34c expression, and induce senescence
Kensuke Kumamoto et al.
CANCER RESEARCH (2008)
Targeting the extrinsic apoptosis pathway in cancer
Avi Ashkenazi
CYTOKINE & GROWTH FACTOR REVIEWS (2008)
The inherent instability of mutant p53 is alleviated by Mdm2 or p16INK4a loss
Tamara Terzian et al.
GENES & DEVELOPMENT (2008)
Inhibition of p53-murine double minute 2 interaction by nutlin-3A stabilizes p53 and induces cell cycle arrest and apoptosis in Hodgkin lymphoma
Elias Drakos et al.
CLINICAL CANCER RESEARCH (2007)
DNA binding and selective gene induction by different forms of the p53 protein
F. Mayelzadeh et al.
ONCOGENE (2007)
p53: Guardian of the genome and policeman of the oncogenes
Alejo Efeyan et al.
CELL CYCLE (2007)
Coping with stress: multiple ways to activate p53
H. F. Horn et al.
ONCOGENE (2007)
Transcriptional targets of p53 that regulate cellular proliferation
Lauren Brown et al.
CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION (2007)
Effect of p53 status and STAT1 on chemotherapy-induced, Fas-mediated apoptosis in colorectal cancer
U McDermott et al.
CANCER RESEARCH (2005)
Carcinogenesis, cancer therapy and chemoprevention
MV Blagosklonny
CELL DEATH AND DIFFERENTIATION (2005)
In vivo activation of the p53 pathway by small-molecule antagonists of MDM2
LT Vassilev et al.
SCIENCE (2004)
Phosphorylation of p53 on key serines is dispensable for transcriptional activation and apoptosis
T Thompson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
p53 has a direct apoptogenic role at the mitochondria
M Mihara et al.
MOLECULAR CELL (2003)
Caspase 9 is required for p53-dependent apoptosis and chemosensitivity in a human ovarian cancer cell line
GS Wu et al.
ONCOGENE (2002)
Inhibition of MDM2 by hsp90 contributes to mutant p53 stabilization
YH Peng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Conformational phenotype of p53 is linked to nuclear translocation
SV Gaitonde et al.
ONCOGENE (2000)
p53 gene mutation and ink4a-arf deletion appear to be two mutually exclusive events in human glioblastoma
G Fulci et al.
ONCOGENE (2000)
INK4a/ARF locus alterations in human non-Hodgkin's lymphomas mainly occur in tumors with wild-type p53 gene
M Pinyol et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
The ARF/p53 pathway
CJ Sherr et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2000)
Share Paper
